VIVOTEK's consolidated sales revenues for September 2025 totaled USD $17.91 million, representing a 8.9 percent increase as compared to USD $16.45 million for August 2025 and a 11.7 percent decrease as compared to USD 20.28 million for September 2024.

The Company's cumulative consolidated sales revenues from January to September in 2025 were USD $181.5 million, a 14 percent increase as compared to USD $159.27 million for the same period in 2024.